We are live on ! Find out more
AWH

Aspira Women's Health Inc. Common Stock

Delisted

AWH was delisted on the 16th of April, 2025.

58 hedge funds and large institutions have $4.46M invested in Aspira Women's Health Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% less funds holding

Funds holding: 7258 (-14)

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

33% less capital invested

Capital invested by funds: $6.65M → $4.46M (-$2.19M)

62% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 21

Holders
58
Holders Change
-14
Holders Change %
-19.44%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
11
Reduced
16
Closed
21
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
+$161 +15 +136%

AWH Hedge Fund Activity: Q3 2022 in Review

58 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Aspira Women's Health Inc. Common Stock (AWH) for Q3 2022, worth a combined $4.46M — down 33% from $6.65M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of AWH and 8 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 11 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.13M. The largest seller was Renaissance Technologies, cutting an estimated $391K.

  • 58 institutional investors held Aspira Women's Health Inc. Common Stock (AWH) as of Q3 2022, down from 72 in Q2 2022.
  • Funds reported $4.46M of Aspira Women's Health Inc. Common Stock stock for Q3 2022, down 33% quarter-over-quarter.
  • 8 funds opened new Aspira Women's Health Inc. Common Stock positions in Q3 2022 and 21 closed out, a net change of -13 holders.
  • The largest Aspira Women's Health Inc. Common Stock buyer in Q3 2022 was Sabby Management, an estimated $1.13M added.
  • The largest Aspira Women's Health Inc. Common Stock seller in Q3 2022 was Renaissance Technologies, an estimated $391K sold.

Based on aggregated 13F filings for Q3 2022.